|
|
|
|
| LEADER |
00000cam a2200000 i 4500 |
| 001 |
EBSCO_ocn958984679 |
| 003 |
OCoLC |
| 005 |
20231017213018.0 |
| 006 |
m o d |
| 007 |
cr ||||||||||| |
| 008 |
160415s2016 nyua ob 001 0 eng |
| 010 |
|
|
|a 2019721377
|
| 040 |
|
|
|a DLC
|b eng
|e rda
|c DLC
|d N$T
|d EBLCP
|d OCLCF
|d SNK
|d DKU
|d AUW
|d IGB
|d D6H
|d VTS
|d AGLDB
|d AU@
|d G3B
|d S8J
|d S9I
|d STF
|d OCLCO
|d OCLCQ
|
| 020 |
|
|
|a 9781634852975
|q pdf
|
| 020 |
|
|
|a 1634852974
|
| 020 |
|
|
|z 9781634852210
|q hardcover
|
| 035 |
|
|
|a (OCoLC)958984679
|
| 050 |
0 |
0 |
|a RC365
|
| 072 |
|
7 |
|a HEA
|x 039000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 014000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 022000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 112000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 045000
|2 bisacsh
|
| 082 |
0 |
0 |
|a 616.8/047
|2 23
|
| 049 |
|
|
|a UAMI
|
| 245 |
0 |
0 |
|a Progressive cognitive impairment and its neuropathologic correlates /
|c Gediminas Peter Gliebus, editor.
|
| 264 |
|
1 |
|a New York :
|b Nova Biomedical,
|c [2016]
|
| 300 |
|
|
|a 1 online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 347 |
|
|
|a data file
|2 rda
|
| 490 |
1 |
|
|a Neurodevelopmental diseases--laboratory and clinical research
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 588 |
|
|
|a Description based on print version record.
|
| 505 |
0 |
|
|a PROGRESSIVE COGNITIVE IMPAIRMENT AND ITS NEUROPATHOLOGIC CORRELATES; PROGRESSIVE COGNITIVE IMPAIRMENT AND ITS NEUROPATHOLOGIC CORRELATES; Library of Congress Cataloging-in-Publication Data; CONTENTS; FOREWORD; INTRODUCTION; Chapter 1: NEUROPATHOLOGY OF NEURODEGENERATIVE DISORDERS; ABSTRACT; BRAIN EXAMINATION AND SECTIONS; ALZHEIMER DISEASE NEUROPATHOLOGIC CHANGE; LEWY BODY DISEASE; FRONTOTEMPORAL LOBAR DEGENERATION; PICK DISEASE (FTLD-TAU, PID); PROGRESSIVE SUPRANUCLEAR PALSY (FTLD-TAU, PSP); CORTICOBASAL DEGENERATION (FTLD-TAU, CBD)
|
| 505 |
8 |
|
|a FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP-43 PROTEINOPATHY (FTLD-TDP)FTLD-FUS; PRION DISEASE; SUMMARY; REFERENCES; Chapter 2: IMAGING AND CEREBROSPINAL FLUID BIOMARKERS IN ALZHEIMER'S DISEASE AND LEWY BODY SPECTRUM DISORDERS; ABSTRACT; GLOSSARY; 1. INTRODUCTION; 2. BIOMARKERS DERIVED FROM STRUCTURAL MAGNETIC RESONANCE IMAGING (MRI) IN AD AND LBD; 2.1. Cross-sectional Profiles of Cerebral Atrophy; 2.2. Longitudinal Rates of Cerebral Atrophy; 2.3. Atrophy Patterns in Medial Temporal Lobe Structures; 2.3.1. Hippocampus; 2.3.2. Entorhinal Cortex; 2.3.3. Subcortical Structures
|
| 505 |
8 |
|
|a 2.4. White Matter Hyperintensities3. BIOMARKERS DERIVED FROM DIFFUSION TENSOR IMAGING (DTI) IN AD AND LBD; 4. BIOMARKERS DERIVED FROM POSITRON EMISSION TOMOGRAPHY (PET) IN AD AND LBD; 4.1. Role of FDG-PET; 4.2. Role of Amyloid PET; 4.3. Role of Acetylcholine Esterase Activity on PET; 5. BIOMARKERS DERIVED FROM SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) IN AD AND LBD; 6. PROTON MAGNETIC RESONANCE SPECTROSCOPY (1H-MRS) AS A BIOMARKER IN AD AND LBD; 7. BIOMARKERS DERIVED FROM FUNCTIONAL MAGNETIC RESONANCE IMAGING (FMRI) IN AD AND LBD
|
| 505 |
8 |
|
|a 8. [123I]METAIODOBENZYLGUANIDINE ([123I]MIBG) MYOCARDIAL SCINTIGRAPHY TO ASSESS AUTONOMIC DYSFUNCTION IN AD AND LBD9. CEREBROSPINAL FLUID (CSF) BIOMARKERS IN AD AND LBD; CONCLUSION; ACKNOWLEDGMENTS; REFERENCES; Chapter 3: FUNCTION AND DYSFUNCTION OF THE PREFRONTAL LOBES IN NEURODEGENERATIVE DISEASES; ABSTRACT; TERMINOLOGY; NEUROANATOMY OF PREFRONTAL FUNCTIONS; Stuss' Model of Prefrontal Function; Cortico-Striato-Pallido-Thalamo-Cortical Loops; Integration of the Two Models; Larger-Scale Frontal Networks; CLINICAL ASSESSMENT OF PREFRONTAL FUNCTIONS; Dorsolateral Prefrontal Functions
|
| 505 |
8 |
|
|a Medial Prefrontal FunctionsOrbitofrontal Functions; Frontal Polar Functions; DISORDERS OF PREFRONTAL FUNCTIONS IN NEURODEGENERATIVE DISEASES; Subcortical Dementias; Behavioural Variant Frontotemporal Dementia (bvFTD); Behavioural/Dysexecutive Variant of Alzheimer's Disease; ACKNOWLEDGMENTS; REFERENCES; Chapter 4: ACTION-INTENTIONAL DISORDERS IN NEURODEGENERATIVE DISEASES; ABSTRACT; MOVEMENT-ACTION PROGRAMMING: "HOW" AND "WHEN"; RELATIONSHIPS BETWEEN COMPONENTS OF SENSORY-ATTENTION AND ACTION-INTENTION; ACTION-INTENTIONAL DISORDERS; Impaired Initiation; Akinesia; Defective Response Inhibition
|
| 590 |
|
|
|a eBooks on EBSCOhost
|b EBSCO eBook Subscription Academic Collection - Worldwide
|
| 650 |
|
0 |
|a Nervous system
|x Degeneration.
|
| 650 |
|
2 |
|a Neurodegenerative Diseases
|
| 650 |
|
7 |
|a HEALTH & FITNESS / Diseases / General
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL / Clinical Medicine
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL / Diseases
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL / Evidence-Based Medicine
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL / Internal Medicine
|2 bisacsh
|
| 650 |
|
7 |
|a Nervous system
|x Degeneration.
|2 fast
|0 (OCoLC)fst01036090
|
| 700 |
1 |
|
|a Gliebus, Gediminas Peter,
|e editor.
|
| 776 |
0 |
8 |
|i Print version:
|t Progressive cognitive impairment and its neuropathologic correlates
|d New York : Nova Biomedical, [2016]
|z 9781634852210 (hardcover)
|w (DLC) 2016939079
|
| 830 |
|
0 |
|a Neurodevelopmental diseases--laboratory and clinical research series.
|
| 856 |
4 |
0 |
|u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1356586
|z Texto completo
|
| 938 |
|
|
|a EBSCOhost
|b EBSC
|n 1356586
|
| 938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL4698073
|
| 994 |
|
|
|a 92
|b IZTAP
|
